Corporate News 08-Mar-23
Board of Natco Pharma approves buyback of shares up to Rs 700 cr
At meeting held on 08 March 2023
The Board of Natco Pharma at its meeting held on 08 March 2023 has approved the a proposal for buyback of shares up to 30,00,000 fully paid up equity shares of face value of Rs 2 each at a price not exceeding Rs 700 per share payable in cash for an aggregate amount not exceeding Rs 210 crore
Previous News
Natco Pharma Ltd spurts 0.67%, gains for fifth straight session
( Hot Pursuit - 03-Jan-24 13:00 )
Board of Natco Pharma recommends Second Interim Dividend
( Corporate News - 11-Nov-22 10:43 )
Natco Pharma Ltd spurts 1.79%
( Hot Pursuit - 26-Dec-23 13:05 )
Volumes jump at Vardhman Textiles Ltd counter
( Hot Pursuit - 03-Mar-23 14:30 )
Natco Pharma
( Results - Analysis 01-Dec-21 18:49 )
Natco Pharma Ltd down for fifth straight session
( Hot Pursuit - 14-Nov-22 13:35 )
Natco Pharma
( Results - Analysis 10-Aug-23 10:40 )
Natco Pharma update on lawsuit for Glatiramer Acetate Injection
( Corporate News - 25-May-22 14:04 )
Natco Pharma gets USFDA nod for lenalidomide capsules
( Hot Pursuit - 22-May-21 15:00 )
Natco Pharma to declare Quarterly Result
( Corporate News - 23-May-22 10:35 )
Natco Pharma receives USFDA approval for Lenalidomide Capsules
( Corporate News - 22-May-21 13:07 )
Other Stories
GAIL (India) signs MoU with AM Green
04-Oct-24 19:27
EaseMyTrip.com resumes bookings to the Maldives
04-Oct-24 19:25
BLS completes acquisition of Dubai-based Citizenship Invest
04-Oct-24 19:23
Insecticides India launches new maize herbicide 'Torry Super'
04-Oct-24 19:21
Landmark Cars receives LoI from Mercedes-Benz India
04-Oct-24 19:19
Astra Microwave Products receives affirmation in credit ratings from CRISIL
04-Oct-24 19:16
Supreme Petrochem receives affirmation in credit ratings
04-Oct-24 19:10
Astec LifeSciences director resigns
04-Oct-24 19:08
Board of Gravita India approves change in directorate
04-Oct-24 19:05
Board of Gravita India approves fund raising up to Rs 1,000 cr
04-Oct-24 19:03
Back
Top
